TABLE 2.
| Variables | Placebo group (n = 23) | Spirulina sauce group (n = 23) | p‐value |
|---|---|---|---|
| Age, years | 35.78 ± 11.14 | 38.87 ± 14.61 | .42 |
| Males, n (%) | 13 (56.5) | 9 (39.1) | .23 |
| NAFLD duration, years | 3.13 ± 1.57 | 3.56 ± 1.59 | .35 |
| Weight, kg | 72.59 ± 11.87 | 69.34 ± 10.09 | .32 |
| BMI, kg/m2 | 25.41 ± 3.45 | 24.67 ± 2.75 | .42 |
| Waist circumference, cm | 95.21 ± 7.10 | 93.78 ± 6.29 | .47 |
| ALT U/L | 37.47 ± 4.37 | 38.86 ± 4.09 | .27 |
| AST, U/L | 21.78 ± 2.66 | 23.13 ± 2.71 | .09 |
| ALP, U/L | 40.52 ± 5.15 | 43.17 ± 5.73 | .10 |
| Fatty liver grade | 1.82 ± 0.65 | 1.78 ± 0.59 | .81 |
| Fasting blood sugar, mg/dl | 87.70 ± 8.63 | 91.43 ± 7.71 | .13 |
| Insulin, μU/ml | 7.36 ± 2.95 | 8.30 ± 3.27 | .31 |
| Triglycerides, mg/dl | 152.83 ± 21.12 | 165.30 ± 41.20 | .20 |
| Total cholesterol, mg/dl | 185.96 ± 39.90 | 202.48 ± 45 | .19 |
| LDL‐C, mg/dl | 117.70 ± 40.62 | 126.96 ± 45.18 | .46 |
| HDL‐C, mg/dl | 37.61 ± 11.27 | 42.43 ± 8.28 | .10 |
| MDA, μmol/L | 3.69 ± 0.51 | 4.04 ± 0.44 | .01 |
| TAC, mmol/L | 0.50 ± 0.35 | 0.64 ± 0.26 | .12 |
| SBP, mmHg | 127.91 ± 9.79 | 130.04 ± 7.05 | .40 |
| DBP, mmHg | 91.65 ± 5.62 | 87.60 ± 8.02 | .05 |
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBP, diastolic blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; MDA, malondialdehyde; SBP, systolic blood pressure; TAC, total antioxidant capacity.
The bold value shows a significant difference between the two groups.
a
Data are either means ± SD or n (%).
b
Qualitative variables were examined with chi‐square test; quantitative variables were tested with independent t test.